Concepedia

Kazuya Miyagawa

KM

15

Publications

1.4K

Citations

14

H-Index

2010

Active since

Affiliations

Stanford University(Current)

Kobe Pharmaceutical University

Kobe University

Cardiovascular Institute of the South

Cardiovascular Institute Hospital

Kazuya Miyagawa is an author at Stanford University specializing in medicine, vascular biology, and pulmonary vascular disease.

Top concepts

MedicineVascular BiologyPulmonary Vascular DiseaseCardiologyPhysiologyCell BiologyPublic HealthOxidative StressCardiovascular DiseasePulmonary Hypertension

Publications per year

2010–2023

15

Publications

15

Endothelial Cell–Derived Endothelin-1 Promotes Cardiac Fibrosis in Diabetic Hearts Through Stimulation of Endothelial-to-Mesenchymal Transition

Bambang Widyantoro, Noriaki Emoto, Kazuhiko Nakayama et al. · Circulation · 2010 · 375 citations

BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to Promote Endothelial Cell Survival and Reverse Pulmonary Hypertension

Isabel Diebold, Jan K. Hennigs, Kazuya Miyagawa et al. · Cell Metabolism · 2015 · 213 citations · Full text

Pulmonary Arterial Hypertension, Molecular Physiology, Mitochondrial Function +9

Elafin Reverses Pulmonary Hypertension via Caveolin-1–Dependent Bone Morphogenetic Protein Signaling

Nils Nickel, Edda Spiekerkoetter, Mingxia Gu et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 158 citations · Full text

Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension

Yu Taniguchi, Kazuya Miyagawa, Kazuhiko Nakayama et al. · EuroIntervention · 2014 · 122 citations

Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension

Pin-I Chen, Aiqin Cao, Kazuya Miyagawa et al. · JCI Insight · 2017 · 99 citations · Full text

Rows per page

1–5 of 15